Epidermal growth factor-induced cyclooxygenase-2 expression is mediated through phosphatidylinositol-3 kinase, not mitogen-activated protein/extracellular signal-regulated kinase kinase, in recurrent respiratory papillomas

Clinical Cancer Research

Volumn 11, Issue 17, 2005, Pages 6155-6161

  Wu, Rong ^a,b   Abramson, Allan L ^b   Shikowitz, Mark J ^b   Dannenberg, Andrew J ^c   Steinberg, Bettie M ^a,b  

^a North Shore Long Island Jewish Health System ^*  (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN E2;

APOPTOSIS; ARTICLE; CANCER GROWTH; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; EXPLANT; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; PAPILLOMA; POSITIVE FEEDBACK; PRECANCER; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; RECURRENT RESPIRATORY PAPILLOMA; RESPIRATORY TRACT TUMOR; SIGNAL TRANSDUCTION; TUMOR RECURRENCE; WART VIRUS; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; EPIDERMAL GROWTH FACTOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEEDBACK, BIOCHEMICAL; HUMANS; IMMUNOENZYME TECHNIQUES; LARYNGEAL NEOPLASMS; LARYNX; MEMBRANE PROTEINS; NEOPLASM RECURRENCE, LOCAL; PAPILLOMA; PAPILLOMAVIRIDAE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RESPIRATORY TRACT NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SULFONAMIDES;

EID: 24344477064     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-2664     Document Type: Article

References (39)

1. Gissmann L, Diehl B, Schults-Coulon J, zur Hausen H. Molecular cloning and characterization of human papillomavirus DNA derived from a laryngeal papilloma. J Virol 1982;44:393-9.
2. Steinberg BM, Meade R, Kalinowski S, Abramson AL. Abnormal differentiation of human papillomavirus-induced laryngeal papillomas. Arch Otolaryngol Head Neck Surg 1990;116:1167-71.
3. Johnston D, Hall H, Di Lorenzo TP, Steinberg BM. Elevation of the epidermal growth factor receptor and dependent signaling in human papillomavirus-infected laryngeal papillomas. Cancer Res 1999;59:968-74.
4. Vambutas A, Di Lorenzo TP, Steinberg BM. Laryngeal papilloma cells have high levels of epidermal growth factor receptor and respond to epidermal growth factor by a decrease in epithelial differentiation. Cancer Res 1993;53:910-4.
5. Zhang P, Steinberg BM. Overexpression of PTEN/MMAC1 and decreased activation of Akt in human papillomavirus-infected laryngeal papillomas. Cancer Res 2000;60:1457-62.
6. Vancurova I, Wu R, Miskolci V, Sun S. Increased p50/ p50 NF-κB activation in human papillomavirus type 6- or type 11-induced laryngeal papilloma tissue. J Virol 2002;76:1533-6.
7. Sun S, Steinberg BM. PTEN is a negative regulator of STAT3 activation in human papillomavirus-infected cells. J Gen Virol 2002;83:1651-8.
8. Wu R, Sun S, Steinberg BM. Requirement of STAT3 activation for differentiation of mucosal stratified squamous epithelium. Mol Med 2003;9:77-84.
9. Turini ME, DuBois RN. Cyclooxygenase-2: a therapeutic target. Annu Rev Med 2002;53:35-57.
10. Kulkarni S, Rader JS, Zhang F, et al. Cyclooxygenase-2 is overexpressed in human cervical cancer. Clin Cancer Res 2001;7:429-34.
11. Golijanin D, Tan JY, Kazior A, et al. Cyclooxygenase-2 and microsomal prostaglandin E synthase-1 are overexpressed in squamous cell carcinoma of the penis. Clin Cancer Res 2004;10:1024-31.
12. Robinson AB, Das SK, Bruegger DE, Hoover LA, Sanford TR. Characterization of cyclooxygenase in laryngeal papilloma by molecular techniques. Laryngoscope 1999;109:1137-41.
13. Banerjee AG, Gopalakrishnan VK, Bhattacharya I, Vishwanatha JK. Deregulated cyclooxygenase-2 expression in oral premalignant tissues. Mol Cancer Ther 2002;1:1265-71.
14. Chan G, Boyle JO, Yang EK, et al. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res 1999; 59:991-4.
15. Ranelletti FO, Almadori G, Rocca B, et al. Prognostic significance of cyclooxygenase-2 in laryngeal squamous cell carcinoma. Int J Cancer 2001;95:343-9.
16. Subbmaramiah K, Dannenberg AJ. Cyclooxygenase 2: a molecular target for cancer prevention and treatment. Trends Pharmacol Sci 2003;24:96-102.
17. 2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor. J Biol Chem 2003;24:24.
18. 2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med 2002;8:289-93.
19. 2 stimulates the growth of colon cancer cells via induction of amphiregulin. Cancer Res 2003;63: 5218-23.
20. Steinberg BM, Abramson AL, Meade RP. Culture of human laryngeal papilloma cells in vivo. Otolaryngol Head Neck Surg 1982;90:728-35.
21. Eichner R, Bonitz P, Sun TT. Classification of epidermal keratins according to their immunoreactivity, isoelectric point, and mode of expression. J Cell Biol 1984;98:1388-96.
22. Laborda J. 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Res 1991;19:3998.
23. Auborn KJ, Fan S, Rosen EM, et al. Indole-3-carbinol is a negative regulator of estrogen. J Nutr 2003; 133:2470-5.
24. Arun B, Goss P. The role of COX-2 inhibition in breast cancer treatment and prevention. Semin Oncol 2004;31:22-9.
25. Poetker DM, Sandler AD, Scott DL, Smith RJ, Bauman NM. Survivin expression in juvenile-onset recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 2002;111:957-61.
26. Steinberg BM, Gallagher T, Stoler M, Abramson AL. Persistence and expression of human papillomavirus during Interferon therapy. Arch Otolaryngol Head Neck Surg 1988;114:27-32.
27. Jang BC, Kim DH, Park JW, et al. Induction of cyclooxygenase-2 in macrophages by catalase: role of NF-κB and PI3K signaling pathways. Biochem Biophys Res Commun 2004;316:398-406.
28. Weaver SA, Russo MP, Wright KL, et al. Regulatory role of phosphatidylinositol 3-kinase on TNF-α-induced cyclooxygenase 2 expression in colonic epithelial cells. Gastroenterology 2001;120:1117-27.
29. Papakonstanti EA, Stournaras C. Association of PI-3-kinase with PAK1 leads to actin phosphorylation and cytoskeletal reorganization. Mol Biol Cell 2002;13:2946-62.
30. Adderley SR, Fitzgerald DJ. Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2. J Biol Chem 1999;274:5038-46.
31. Wadleigh DJ, Reddy ST, Kopp E, Ghosh S, Herschman HR. Transcriptional activation of the cyclooxygenase-2 gene in endotoxin-treated RAW 264.7 macrophages. J Biol Chem 2000;275: 6259-66.
32. Coffey JR, Hawkey CJ, Damstrup L, et al. Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells. Proc Natl Acad Sci U S A 1997;94:657-62.
33. 2 synergistically enhances receptor tyrosine kinase-dependent signaling system in colon cancer cells. J Biol Chem 2004;279:14287-93.
34. Lin M-T, Lee RC, Yang PC, Ho FM, Kuo ML. Cyclooxygenase-2 inducing mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1.0 cells. J Biol Chem 2001;276:48997-9002.
35. 2 increases growth and motility of colorectal carcinoma cells. J Biol Chem 2001;276: 18075-81.
36. Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci U S A 1997; 94:3336-40.
37. Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing Prostaglandin endoperoxide synthase 2. Cell 1995; 83:493-501.
38. Krysan K, Dalwadi H, Sharma S, Pold M, Dubinett S. Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer. Cancer Res 2004;64:6359-62.
39. Krysan K, Merchant FH, Zhu L, et al. COX-2-dependent stabilization of survivin in non-small cell lung cancer. FASEB J 2004;18:206-8.